Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.32 |
| ▸ | RET | P07949 | 1/20 | 0.32 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.32 |
| ▸ | CDK2 | P24941 | 2/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24741784 | 1.00 | CYP3A4 (0.38) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL29987402 | 1.00 | CYP3A4 (0.38) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL29987681 | 1.00 | CYP3A4 (0.38) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL29207594 | 1.00 | CYP3A4 (0.38) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL31503458 | 1.00 | CYP3A4 (0.38) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL2419398 | 0.86 | CYP3A4 (0.43) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL17387673 | 0.86 | CYP3A4 (0.43) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL24742033 | 0.84 | CYP3A4 (0.36) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL25784117 | 0.82 | CYP3A4 (0.35) | CYP3A4GAACYP2C19NPC1LMNA | |
| SCHEMBL24741965 | 0.80 | CYP3A4 (0.46) | CYP3A4GAACYP2C19TGFBR1CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4587438-A1 | BICYCLIC COMPOUNDS AS CDK INHIBITORS | BeiGene Switzerland GmbH (CH) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025062334-A1 | 4-((5-(3-(4-(PYRIDIN-2-YL)CYCLOPENTYL)-1 H-PYRAZOL-3-YL)AMINO)-BENZENESULFONAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS CDK INHIBITORS FOR THE TREATMENT OF CANCER | BEIGENE SWITZERLAND GMBH (CH) | 2025-03-27 | — | — | WO | disclosed |
| CN-118019734-A | Cyclopentyl pyrazole CDK2 inhibitors | 基因泰克公司 | 2024-05-10 | — | — | CN | disclosed |
| WO-2023141852-A1 | CDK2 INHIBITORS, PREPARATION METHOD THEREFOR AND USE THEREOF | 益方生物科技(上海)股份有限公司 | 2023-08-03 | — | — | WO | disclosed |
| WO-2022206888-A1 | CDK2 INHIBITORS AND USE THEREOF | QILU REGOR THERAPEUTICS INC. (CN) | 2022-10-06 | — | — | WO | disclosed |